Tyra Biosciences' shares have dropped sharply after interim data from TYRA-300 showed a superior but not exceptional adverse ...

(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, 2024, was host to the Bladder Cancer Course and the session Metastatic ...

Craig A Clifford, DVM, MS, DACVIM (Oncology) talks about the most common bladder tumor in dogs, misdiagnosis, and the Cadet ...

Urothelial carcinoma (UC), also known as transitional cell carcinoma (TCC), is the most common form of bladder cancer in dogs ...

A multi-institutional clinical trial led by the University of Navarra, Spain, found that blocking growth differentiation ...

The results of a study into whether cancer detection dogs can smell bladder cancer in other dogs' urine suggests that this ...

(RTTNews) - Gilead Sciences, Inc. (GILD) Tuesday said that the U.S. Food and Drug Administration or FDA has granted Breakthrough Therapy Designation to Trodelvy for the treatment of adults with ...

Dogs trained to detect bladder cancer showed 90% sensitivity and 95% specificity, offering a non-invasive diagnostic method.

Bicycle Therapeutics plc (NASDAQ:BCYC) announced that it presented data showing the enhanced anti-tumor activity of ...

Discover how voided urine cfDNA emerges as a promising biomarker for upper tract urothelial carcinoma, offering a less ...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that ...

Bicycle Therapeutics plc, a company specializing in developing therapeutic solutions based on its proprietary bicyclic peptide technology, revealed significant data updates across its zelenectide ...